BIO Submits Comments on Minimal Manipulation
<p>
The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the Draft Guidance for Industry and FDA Staff entitled “Minimal Manipulation of Human Cells, Tissues, and Cellular and Tissue-Based Products” (HCT/P).</p>
The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the Draft Guidance for Industry and FDA Staff entitled “Minimal Manipulation of Human Cells, Tissues, and Cellular and Tissue-Based Products” (HCT/P).
